A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : RECIST

Search Conditions:
Search Keyword : RECIST
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: RECIST
Appearance Frequency: 1231 time(s)
Long forms: 18

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
Response Evaluation Criteria in Solid Tumors
(1200 times)
Neoplasms
(653 times)
PFS (182 times)
OS (169 times)
PR (148 times)
2000 [New guidelines to evaluate the response to treatment "RECIST"].
Response Criteria in Solid Tumors
(14 times)
Neoplasms
(6 times)
OS (5 times)
ICC (3 times)
PFS (3 times)
2005 Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors.
response criteria of evaluation in solid tumors
(2 times)
Breast Neoplasms
(1 time)
sst (2 times)
CTCAE (1 time)
NET (1 time)
2012 NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial.
Radiographic Evaluation Criteria in Solid Tumors
(1 time)
Gynecology
(1 time)
GCIG (1 time)
PFI (1 time)
PFS (1 time)
2012 Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.
radiologic assessment
(1 time)
Radiology
(1 time)
aRDM (1 time)
CR (1 time)
EDM (1 time)
2015 Comparison of volumetric and linear serial CT assessments of lung metastases in renal cell carcinoma patients in a clinical phase IIB study.
radiological criteria in solid tumours
(1 time)
Radiology
(1 time)
HCC (1 time)
mRECIST (1 time)
RECICL (1 time)
2018 Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.
response according to change in size
(1 time)
Neoplasms
(1 time)
CC (1 time)
CR (1 time)
SBRT (1 time)
2013 Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking.
response as assigned by CT
(1 time)
Neoplasms
(1 time)
PET (1 time)
SCLC (1 time)
2006 PET/CT imaging in response evaluation of patients with small cell lung cancer.
Response Assessment Criteria in Solid Tumors
(1 time)
Neoplasms
(1 time)
CT (1 time)
MASS (1 time)
MSKCC (1 time)
2013 Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.
10  response at all times including preoperative evaluation
(1 time)
Gastroenterology
(1 time)
CRT (1 time)
HCC (1 time)
pCR (1 time)
2016 Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.
11  response criteria
(1 time)
Neoplasms
(1 time)
BF (1 time)
BV (1 time)
PCT (1 time)
2014 Pretreatment perfusion CT and CT volumetry in squamous cell carcinoma of the head and neck region.
12  response evaluation criteria in solid
(1 time)
Complementary Therapies
(1 time)
FCM (1 time)
MN (1 time)
PCS (1 time)
2010 [Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma].
13  response in terms of Evaluation Criteria in Solid Tumors
(1 time)
Antineoplastic Agents
(1 time)
--- 2012 [A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy].
14  response than conventional response assessment
(1 time)
Neoplasms
(1 time)
pCR (1 time)
2016 Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC.
15  response was defined by good short-term efficacy
(1 time)
Medicine
(1 time)
AI (1 time)
CR (1 time)
LACC (1 time)
2018 Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
16  response, the cutoff levels as also used for size measurement
(1 time)
Nuclear Medicine
(1 time)
SUV (1 time)
2007 Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
17  retrospectively by two radiologists regarding diameters
(1 time)
Radiology
(1 time)
--- 2008 Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV--a feasibility study.
18  review the strengths and limitations of CT
(1 time)
Nuclear Medicine
(1 time)
FDG (1 time)
2011 (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.